Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

SELL
$42.56 - $59.82 $1.17 Million - $1.64 Million
-27,439 Reduced 85.92%
4,497 $253,000
Q4 2023

Feb 06, 2024

SELL
$32.18 - $46.57 $28,511 - $41,261
-886 Reduced 2.7%
31,936 $1.43 Million
Q3 2023

Nov 01, 2023

BUY
$44.2 - $50.2 $24,089 - $27,359
545 Added 1.69%
32,822 $1.49 Million
Q2 2023

Aug 09, 2023

SELL
$31.86 - $67.26 $23,002 - $48,561
-722 Reduced 2.19%
32,277 $1.4 Million
Q1 2023

May 12, 2023

BUY
$45.44 - $74.26 $466,805 - $762,872
10,273 Added 45.2%
32,999 $2.17 Million
Q4 2022

Feb 03, 2023

BUY
$41.39 - $81.0 $101,446 - $198,531
2,451 Added 12.09%
22,726 $1.02 Million
Q3 2022

Nov 03, 2022

BUY
$72.36 - $113.1 $86,614 - $135,380
1,197 Added 6.27%
20,275 $1.47 Million
Q2 2022

Jul 25, 2022

BUY
$87.2 - $114.05 $1.1 Million - $1.44 Million
12,599 Added 194.46%
19,078 $2.05 Million
Q1 2022

Apr 25, 2022

SELL
$94.19 - $124.49 $10,737 - $14,191
-114 Reduced 1.73%
6,479 $719,000
Q4 2021

Jan 31, 2022

BUY
$119.57 - $139.07 $22,240 - $25,867
186 Added 2.9%
6,593 $844,000
Q3 2021

Nov 04, 2021

SELL
$109.17 - $142.35 $34,279 - $44,697
-314 Reduced 4.67%
6,407 $853,000
Q2 2021

Jul 27, 2021

SELL
$100.34 - $115.69 $87,998 - $101,460
-877 Reduced 11.54%
6,721 $726,000
Q1 2021

Jun 02, 2021

SELL
$101.51 - $125.27 $49,130 - $60,630
-484 Reduced 5.99%
7,598 $801,000
Q4 2020

Feb 05, 2021

SELL
$85.88 - $105.36 $18,464 - $22,652
-215 Reduced 2.59%
8,082 $841,000
Q3 2020

Oct 15, 2020

SELL
$72.74 - $92.5 $21,676 - $27,565
-298 Reduced 3.47%
8,297 $711,000
Q2 2020

Jul 27, 2020

BUY
$48.02 - $79.04 $96,088 - $158,159
2,001 Added 30.35%
8,595 $630,000
Q1 2020

Apr 29, 2020

BUY
$36.95 - $62.95 $39,979 - $68,111
1,082 Added 19.63%
6,594 $343,000
Q4 2019

Feb 03, 2020

SELL
$47.06 - $56.64 $752 - $906
-16 Reduced 0.29%
5,512 $310,000
Q3 2019

Oct 24, 2019

SELL
$47.45 - $58.05 $29,988 - $36,687
-632 Reduced 10.26%
5,528 $264,000
Q2 2019

Jul 19, 2019

SELL
$39.26 - $54.21 $5,535 - $7,643
-141 Reduced 2.24%
6,160 $334,000
Q1 2019

Apr 19, 2019

SELL
$29.84 - $43.92 $7,519 - $11,067
-252 Reduced 3.85%
6,301 $256,000
Q4 2018

Jan 28, 2019

BUY
$29.95 - $46.34 $11,680 - $18,072
390 Added 6.33%
6,553 $205,000
Q3 2018

Oct 22, 2018

BUY
$40.12 - $45.55 $922 - $1,047
23 Added 0.37%
6,163 $281,000
Q2 2018

Jul 26, 2018

SELL
$38.72 - $42.52 $35,970 - $39,501
-929 Reduced 13.14%
6,140 $257,000
Q1 2018

Apr 18, 2018

SELL
$39.4 - $47.39 $17,769 - $21,372
-451 Reduced 6.0%
7,069 $290,000
Q4 2017

Jan 18, 2018

SELL
$37.27 - $43.02 $8,087 - $9,335
-217 Reduced 2.8%
7,520 $309,000
Q3 2017

Oct 23, 2017

BUY
$33.75 - $41.67 $261,123 - $322,400
7,737
7,737 $309,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.7B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Regions Financial Corp Portfolio

Follow Regions Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Regions Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Regions Financial Corp with notifications on news.